FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to pediatrics. In order to realise method of prognosis of efficiency of bronchial asthma basic therapy level of nitrogen oxide in exhaled air (NOex) is determined in combination with immunologic indices. High levels of NOex and IgE with level of circulating immune complex (CIC) and precipitating antibodies (PA) in blood serum being within normal allow to prognose efficiency of standard basic therapy and high informativity of NOex level monitoring. Slightly higher or within normal level of NOex with normal level of IgE, high level of (CIC) and precipitating antibodies (PA) in blood serum points to low efficiency of standard basic therapy and uninformativity of NOex level monitoring.
EFFECT: ensuring prognosis of treatment efficiency in order to obtain control over disease by selecting optimal therapy by means of monitoring nitrogen oxide level in exhaled air.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF INDICATIONS TO PREVENTIVE INCREASE OF VOLUME OF BASIC THERAPY BY GLUCOCORTICOSTEROIDS INHALATION AT CHILDREN WITH BRONCHIAL ASTHMA AGAINST JOINING OF ACUTE RESPIRATORY INFECTION | 2007 |
|
RU2365338C2 |
| METHOD OF PREDICTING UNCONTROLLED COURSE OF SEVERE BRONCHIAL ASTHMA | 2011 |
|
RU2470582C1 |
| METHOD FOR PREDICTION OF THERAPEUTIC EFFICACY OF SEVERE BRONCHIAL ASTHMA | 2013 |
|
RU2530616C1 |
| METHOD OF ESTIMATING LEVEL OF BRONCHIAL ASTHMA CONTROL IN CHILDREN | 2011 |
|
RU2458634C1 |
| METHOD OF SELECTING DURATION OF THE THERAPEUTIC COURSE WITH CERULOPLASMIN IN PATIENTS WITH BRONCHIAL ASTHMA | 2015 |
|
RU2603468C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF THERAPEUTIC RESISTANCE IN PATIENTS WITH BRONCHIAL ASTHMA | 2010 |
|
RU2433401C1 |
| METHOD FOR PREDICTING THE COURSE OF BRONCHIAL ASTHMA IN PREGNANT WOMEN | 2016 |
|
RU2659170C2 |
| DIAGNOSTIC TECHNIQUE FOR CONTROLLING BRONCHIAL ASTHMA IN CHILDREN WITH ATOPIC DERMATITIS | 2019 |
|
RU2706377C1 |
| METHOD FOR PREVENTING PARTIALLY CONTROLLED BRONCHIAL ASTHMA CAUSED BY MANGANESE AND VANADIUM EXPOSURE IN CHILDREN AGED 5 AND OLDER | 2014 |
|
RU2546525C1 |
| METHOD OF PREVENTING DEVELOPMENT OF UNCONTROLLED BRONCHIAL ASTHMA FORMS INDUCED BY MANGANESE AND VANADIUM IMPACT IN CHILDREN OVER 5 YEARS OLD | 2014 |
|
RU2555341C1 |
